The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission

Hearing Status Clinical Trial

Official title:

The Effect of Continuous, Various Dosages of Furosemide Drip on Hearing as Measured by Acoustic Emission

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00945386
• Other study ID #: 005418
• Status: Not yet recruiting
• Phase: N/A
• First received: July 23, 2009
• Last updated: July 23, 2009
• Start date: August 2009
• Est. completion date: August 2010

Study information

• Verified date: July 2009
• Source: Rabin Medical Center
• Contact: Elhanan - Nahum, MD
• Phone: 972 3 9253686
• Email: enahum[@]clalit.org.il
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose).

This study will monitor hearing status of these children prior to their therapy with furosemide, during this therapy and after.

Description:

This study will record hearing status, by acoustic emission, of critically ill children, treated with different dosages of furosemide drip.

Acoustic emission test will be done prior to therapy and q48 hours during their course of treatment with furosemide drip.

Dosage of furosemide drip, boluses and other relevant medications (i.e - vancomycin, muscular relaxants, aminoglycosides etc) will be recorded.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: August 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 1 Month to 18 Years

Eligibility

Inclusion Criteria:

• All children admitted to Pediatric ICU who are treated with furosemide continuous drip.

Exclusion Criteria:

• Children with known hearing abnormalities prior to treatment.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Hearing Status

Locations

Country	Name	City	State
Israel	Pediatric ICU, Schneider Children's Hospital	Petah Tikva

Sponsors (1)

Lead Sponsor	Collaborator
Rabin Medical Center

Country where clinical trial is conducted

Israel,